NOVARTIS | ASPIRE & INNOVATIVE ADVERTISING LTD. | NOVARTIS/ ASPIRE & INNOVATIVE ADVERTISING LTD. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 27.2 | - | - | View Chart |
P/BV | x | 3.4 | 7.9 | 42.2% | View Chart |
Dividend Yield | % | 4.5 | 0.0 | - |
NOVARTIS ASPIRE & INNOVATIVE ADVERTISING LTD. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
NOVARTIS Mar-23 |
ASPIRE & INNOVATIVE ADVERTISING LTD. Mar-23 |
NOVARTIS/ ASPIRE & INNOVATIVE ADVERTISING LTD. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 763 | NA | - | |
Low | Rs | 554 | NA | - | |
Sales per share (Unadj.) | Rs | 153.4 | 3,114.6 | 4.9% | |
Earnings per share (Unadj.) | Rs | 41.9 | 47.8 | 87.5% | |
Cash flow per share (Unadj.) | Rs | 44.3 | 50.5 | 87.8% | |
Dividends per share (Unadj.) | Rs | 47.50 | 0 | - | |
Avg Dividend yield | % | 7.2 | 0 | - | |
Book value per share (Unadj.) | Rs | 314.2 | 139.7 | 224.8% | |
Shares outstanding (eoy) | m | 24.69 | 1.11 | 2,224.3% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 4.3 | 0 | - | |
Avg P/E ratio | x | 15.7 | 0 | - | |
P/CF ratio (eoy) | x | 14.9 | 0 | - | |
Price / Book Value ratio | x | 2.1 | 0 | - | |
Dividend payout | % | 113.5 | 0 | - | |
Avg Mkt Cap | Rs m | 16,262 | 0 | - | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 356 | 36 | 981.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 3,787 | 3,457 | 109.6% | |
Other income | Rs m | 581 | 5 | 12,031.1% | |
Total revenues | Rs m | 4,369 | 3,462 | 126.2% | |
Gross profit | Rs m | 651 | 74 | 879.9% | |
Depreciation | Rs m | 61 | 3 | 2,061.2% | |
Interest | Rs m | 18 | 4 | 454.5% | |
Profit before tax | Rs m | 1,154 | 72 | 1,602.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 120 | 19 | 635.3% | |
Profit after tax | Rs m | 1,034 | 53 | 1,946.9% | |
Gross profit margin | % | 17.2 | 2.1 | 803.2% | |
Effective tax rate | % | 10.4 | 26.3 | 39.6% | |
Net profit margin | % | 27.3 | 1.5 | 1,777.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 7,861 | 580 | 1,354.6% | |
Current liabilities | Rs m | 2,683 | 423 | 633.7% | |
Net working cap to sales | % | 136.7 | 4.5 | 3,011.5% | |
Current ratio | x | 2.9 | 1.4 | 213.8% | |
Inventory Days | Days | 1,201 | 4 | 27,196.9% | |
Debtors Days | Days | 35 | 203 | 17.2% | |
Net fixed assets | Rs m | 12,656 | 44 | 28,672.2% | |
Share capital | Rs m | 123 | 11 | 1,110.7% | |
"Free" reserves | Rs m | 7,634 | 144 | 5,300.7% | |
Net worth | Rs m | 7,757 | 155 | 5,000.6% | |
Long term debt | Rs m | 0 | 45 | 0.0% | |
Total assets | Rs m | 20,517 | 624 | 3,285.8% | |
Interest coverage | x | 66.9 | 19.7 | 339.7% | |
Debt to equity ratio | x | 0 | 0.3 | 0.0% | |
Sales to assets ratio | x | 0.2 | 5.5 | 3.3% | |
Return on assets | % | 5.1 | 9.1 | 56.2% | |
Return on equity | % | 13.3 | 34.2 | 38.9% | |
Return on capital | % | 15.1 | 37.8 | 39.9% | |
Exports to sales | % | 2.1 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 80 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 80 | 0 | - | |
Fx outflow | Rs m | 946 | 0 | - | |
Net fx | Rs m | -866 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 448 | -131 | -343.2% | |
From Investments | Rs m | -1,533 | 21 | -7,346.6% | |
From Financial Activity | Rs m | -305 | 74 | -411.0% | |
Net Cashflow | Rs m | -1,389 | -36 | 3,913.5% |
Indian Promoters | % | 0.0 | 0.0 | - | |
Foreign collaborators | % | 70.7 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.7 | 0.0 | - | |
FIIs | % | 0.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.3 | 0.0 | - | |
Shareholders | 41,239 | 0 | - | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare NOVARTIS With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Novartis | ASPIRE & INNOVATIVE ADVERTISING LTD. | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.25% | 4.98% | 0.34% |
1-Month | 1.49% | 36.76% | 0.25% |
1-Year | 77.19% | 36.76% | 54.31% |
3-Year CAGR | 17.43% | 11.00% | 15.04% |
5-Year CAGR | 8.76% | 6.46% | 19.87% |
* Compound Annual Growth Rate
Here are more details on the Novartis share price and the ASPIRE & INNOVATIVE ADVERTISING LTD. share price.
Moving on to shareholding structures...
The promoters of Novartis hold a 70.7% stake in the company. In case of ASPIRE & INNOVATIVE ADVERTISING LTD. the stake stands at 0.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Novartis and the shareholding pattern of ASPIRE & INNOVATIVE ADVERTISING LTD..
Finally, a word on dividends...
In the most recent financial year, Novartis paid a dividend of Rs 47.5 per share. This amounted to a Dividend Payout ratio of 113.5%.
ASPIRE & INNOVATIVE ADVERTISING LTD. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of Novartis, and the dividend history of ASPIRE & INNOVATIVE ADVERTISING LTD..
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.